Novel therapies for myelodysplastic synd
โ
Stefan Faderl; Hagop M. Kantarjian
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 209 KB
## Abstract ## BACKGROUND The assessment of patients with myelodysplastic syndromes (MDS) and the choice of therapies remain challenging. New therapies are now emerging after the identification of molecular targets that result in improvement of hematologic parameters and may hold promise for the p